Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
100.09%Free Cash Flow to Operating Cash Flow
VS
Market
Sector
Industry
History
$ 29.46Close
$ 13.63 - $ 41.99 52-Week Range
Ticker Information
Ticker
RIGLCompany Name
RIGEL PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQRIGEL PHARMACEUTICALS INC - Free Cash Flow to Operating Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
RIGL - FCF/OCF Historical data
| Date | Free Cash Flow | Free Cash Flow to Operating Cash Flow | Net Cash Flow - Operations |
|---|---|---|---|
| 6/30/2025 | $ 65.89M | 100.09% | $ 65.83M |
| 3/31/2025 | $ 35.43M | 99.55% | $ 35.59M |
| 12/31/2024 | $ 31.17M | 99.05% | $ 31.47M |
| 9/30/2024 | $ 10.49M | 97.82% | $ 10.73M |
| 6/30/2024 | $ -12.54M | 0% | $ -12.31M |
| 3/31/2024 | $ -6.69M | 0% | $ -6.68M |
| 12/31/2023 | $ -5.48M | 0% | $ -5.74M |
| 9/30/2023 | $ -20.99M | 0% | $ -21.41M |
| 6/30/2023 | $ -32.86M | 0% | $ -33.35M |
| 3/31/2023 | $ -51.4M | 0% | $ -52.2M |
Key Performance Insights, Last 5 Years
- RIGEL PHARMACEUTICALS INC's latest trailing twelve months (TTM) FCF/OCF stands at 0%.
- Over the past 5 years, RIGEL PHARMACEUTICALS INC's average FCF/OCF has been -24.12%.
- The median FCF/OCF for RIGEL PHARMACEUTICALS INC during this period was 93.58%
- RIGEL PHARMACEUTICALS INC reached its highest FCF/OCF over the past 5 years at 100.09%.
- The lowest FCF/OCF recorded by RIGEL PHARMACEUTICALS INC in the same timeframe -468.6%
RIGEL PHARMACEUTICALS INC's FCF/OCF vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF/OCF Benchmarks
Similar metrics to CF - Operations:
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Net Cash Flow - Operations - [Cash Flow Statement] Cash flow from operations represents the amount of cash inflow (outflow) that a company generates (consumes) from operating activities. Similar to Net Income [NetIncCmn] but harder to manipulate and ignoring effects of non-cash charges like depreciation.
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of Free Cash Flow to Operating Cash Flow
[Calculation] The Free Cash Flow to Cash Flow from Operations ratio, describes how much of a company’s operating cash flow [NCFO] is free to be invested after capital expenditures [CapEx].FCF / CF - Operations
(=) FCF/OCF FCF/OCF for RIGEL PHARMACEUTICALS INC is calculated as follows: FCF [ $ -47.63M ] / CF - Operations [ $ -46.26M ]
(=) FCF/OCF [ 0% ] RIGL - Free Cash Flow to Operating Cash Flow, Last 5 years
-468.6%
Minimum
Jun 30, 2021
100.09%
Maximum
Jun 30, 2025
-24.12%
Average
93.58%
Median
FCF/OCF Benchmark AnalysisMarket
The chart above depicts the distribution of FCF/OCF for companies in the Total Stock Market. The average FCF/OCF of the companies is 71.44% with a standard deviation of 29.12%.
The following table provides additional summary stats:
FCF/OCF in the Market:
| filtered constituents | 2.51K |
|---|---|
| min | -23% |
| max | 171.58% |
| average | 71.44% |
| median | 80.83% |
| std | 29.12% |